Peiying Yang

Dr. Peiying Yang


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Cancer Research
Verified
Journal Article
Open access
PDF file
YJYan Jiang
Yan Jiang
YPYong Pan
Yong Pan
PRPatrea R. Rhea
Patrea R. Rhea
LTLin Tan
Lin Tan
MGMihai Gagea
Mihai Gagea
PYPeiying Yang
Peiying Yang
Epidemiologic studies have shown that dietary sugar intake has a significant impact on the development of breast cancer. One proposed mechanism for how sugar impacts cancer development involves inflammation. In the current study, we investigated the impact of dietary sugar on mammary gland tumor development in multiple mouse models, along with mechanisms that may be involved. We found that sucrose intake in mice comparable with levels of Western diets led to increased tumor growth and metastasis, when compared with a nonsugar starch diet. This effect was ascribed in part to increased expression of 12-lipoxygenase (12-LOX) and its arachidonate metabolite 12-hydroxy-5Z,8Z,10E,14Z-eicosatetraenoic acid (12-HETE). We determined that fructose derived from the sucrose was responsible for facilitating lung metastasis and 12-HETE production in breast tumors. Overall, our data suggested that dietary sugar induces 12-LOX signaling to increase risks of breast cancer development and metastasis. Cancer Res; 76(1); 24–29. ©2016 AACR.

1 June 2014 in Cancer Letters
Verified
Journal Article
Closed access
PYPeiying Yang
Peiying Yang
YJYan Jiang
Yan Jiang
SFSusan M. Fischer
Susan M. Fischer

10 August 2012 in International Journal of Oncology
Verified
Journal Article
Open access
PDF file
PYPeiying Yang
Peiying Yang
CCCarrie A. Cartwright
Carrie A. Cartwright
JLJin Li
Jin Li
Sijin WenSijin Wen
Sijin Wen
IPIna N. Prokhorova
Ina N. Prokhorova
JKJeri Kim
Jeri Kim
The arachidonic acid pathway is important in the development and progression of numerous malignant diseases, including prostate cancer. To more fully evaluate the role of individual cyclooxygenases (COXs), lipoxygenases (LOXs) and their metabolites in prostate cancer, we measured mRNA and protein levels of COXs and LOXs and their arachidonate metabolites in androgen-dependent (LNCaP) and androgen-independent (PC-3 and DU145) prostate cancer cell lines, bone metastasis-derived MDA PCa 2a and MDA PCa 2b cell lines and their corresponding xenograft models, as well as core biopsy specimens of primary prostate cancer and nonneoplastic prostate tissue taken ex vivo after prostatectomy. Relatively high levels of COX-2 mRNA and its product PGE2 were observed only in PC-3 cells and their xenografts. By contrast, levels of the exogenous 12-LOX product 12-HETE were consistently higher in MDA PCa 2b and PC-3 cells and their corresponding xenograft tissues than were those in LNCaP cells. More strikingly, the mean endogenous level of 12-HETE was significantly higher in the primary prostate cancers than in the nonneoplastic prostate tissue (0.094 vs. 0.010 ng/mg protein, respectively; p=0.019). Our results suggest that LOX metabolites such as 12-HETE are critical in prostate cancer progression and that the LOX pathway may be a target for treating and preventing prostate cancer.

31 January 2013 in Molecular Carcinogenesis
Verified
Journal Article
Closed access
PDF file
PYPeiying Yang
Peiying Yang
CCCarrie Cartwright
Carrie Cartwright
DCDiana Chan
Diana Chan
JDJibin Ding
Jibin Ding
EFEdward Felix
Edward Felix
RNRobert A. Newman
Robert A. Newman

8 December 2022 in Cancers
Verified
Journal Article
Open access
PDF file
MEMargeaux Epner
Margeaux Epner
PYPeiying Yang
Peiying Yang
RWRichard Wagner
Richard Wagner
LCLorenzo Cohen
Lorenzo Cohen
Per capita sugar consumption has increased in the United States to over 45 kg per year. The average person in the US currently consumes significantly more added sugar in their diet than the World Health Organization’s, the American Cancer Society’s, and the American Heart Association’s recommendations for daily sugar consumption. Evidence from epidemiologic and preclinical studies demonstrates that excess sugar consumption can lead to development of cancer and progression of disease for those with cancer independent of the association between sugar and obesity. Human epidemiologic studies and mechanistic preclinical studies in multiple cancers support a causal link between excess sugar and cancer. Preclinical studies show that high-sucrose or high-fructose diets activate several mechanistic pathways, including inflammation, glucose, and lipid metabolic pathways. Although human studies are limited, compelling human and primate studies have explored the link between added sugar and metabolic syndrome (MetS), a risk factor for cancer. Substantial evidence suggests a causal link between MetS and added sugar, indicating important implications in the association between excess sugar consumption and cancer. Human clinical trials are needed to determine whether sugar increases cancer development and progression independently of its established role in causing obesity as well as for further exploration of the mechanisms involved.

18 August 2015 in Oncotarget
Verified
Journal Article
Open access
PDF file
LZLiping Zhuang
Liping Zhuang
LXLitao Xu
Litao Xu
PWPeng Wang
Peng Wang
YJYan Jiang
Yan Jiang
PYPan Yong
Pan Yong
PYPeiying Yang
Peiying Yang
Na + /K + -ATPase 1 subunit, a novel therapeutic target for hepatocellular carcinoma Na+/K+-ATPase α1 subunit, a novel therapeutic target for hepatocellular carcinoma